EnteroBiotix appoints former GSK Chief Medical Officer to board

US medical technology company Stryker is investing approximately US$400m (£300m) in UK surgical robotics developer CMR Surgical, alongside securing an …

By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While every medicine undergoes rigorous clinical …

AstraZeneca and Amgen’s Tezspire (tezepelumab) has demonstrated significant improvements in tissue inflammation and swallowing symptoms in patients with eosinophilic oesophagitis …

Diagnostic innovation and patient safety have dominated this year’s healthcare-focussed awards to mark European Laboratory Day. Staged by the European …

Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity fund Silver …

Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for patients who …

Onicor, a medical technology company developing a personalised treatment for onychomycosis (fungal nail infection), has appointed Piet De Doncker as …

A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access treatment sooner and …

Otologist and neurotologist Dr. Peter Weber has been appointed Chief Medical Officer of biotech Sensorion. The company, which develops novel …

Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European Commission as a maintenance treatment for asthma in …

Ramil Burden is the new Chief Executive Officer of Acumetis, announced the company in a recent statement.  Founder and CEO …

Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …

Researchers at Manchester Metropolitan University are investigating whether regular hot-water immersion can improve mobility and relieve pain in people with …

Nuclera, the biotechnology company enabling access to innovative protein technologies, has appointed Carl Raimond as Chief Executive Officer, effective immediately. …

Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …

Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults …

Bramacare has opened a new facility in Ipswich offering supported living for adults recovering from complex eating disorders, providing a …

Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to …

The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of migraine with …